Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Ecological network management provides key mechanistic knowledge on ecosystem degradation that links species- to ecosystem-level responses to global change, and emerging technological tools offer the ...

Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...

Yet, for all the convenience and value Generative AI and large language models (LLMs) deliver, they have a problem. Despite delivering text, video, and images that appear accurate and convincing, they ...

The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.

The macromolecular organization of photosynthetic complexes within the thylakoids of higher plant chloroplasts has been a topic of significant debate. Using in situ cryo-electron tomography, this ...